Stocks and Investing Stocks and Investing
Fri, August 2, 2019
Thu, August 1, 2019

Matthew Kaplan Upgraded (UTHR) to Strong Buy and Increased Target to $106 on, Aug 1st, 2019


Published on 2024-10-26 15:13:33 - WOPRAI, Matthew Kaplan
  Print publication without navigation


Matthew Kaplan of Ladenburg Thalmann, Upgraded "United Therapeutics Corporation" (UTHR) to Strong Buy and Increased Target from $103 to $106 on, Aug 1st, 2019.

Matthew has made no other calls on UTHR in the last 4 months.



There are 3 other peers that have a rating on UTHR. Out of the 3 peers that are also analyzing UTHR, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Martin Auster of "UBS" Upgraded from Strong Sell to Hold and Decreased Target to $94 on, Friday, May 17th, 2019


These are the ratings of the 2 analyists that currently disagree with Matthew


  • M. Auster of "Credit Suisse" Upgraded from Hold to Buy on, Monday, July 1st, 2019
  • Liana Moussatos of "Wedbush" Maintained at Buy with Increased Target to $273 on, Thursday, May 2nd, 2019

Contributing Sources